The Greater Zurich Area is a leading location for top biotech companies in Europe. The region attracts capital and researchers from across the globe. It is home to some of the most innovative businesses in the world. Key European biotechnology companies who chose Greater Zurich include Biogen, Johnson & Johnson, Bluebird Bio and Amgen.

Biotech companies in Greater Zurich can secure opportunities rarely seen in other places, e.g. from the flexible labor laws, a stable economic environment and a highly qualified workforce. Pharmaceutical companies receive the same benefits. The Greater Zurich Area truly is one of the finest biotech hubs in Europe.

The Greater Zurich Area is a European hotspot for medical technology. It’s no coincidence that it is home to a plethora of world-class patents for medtech innovations. Several of the largest medtech companies in Switzerland and even the world are located in the region. Industry leaders like Roche Diagnostics, Zimmer Biomet, Hamilton and Stryker benefit from the region’s advantages.

Companies have access to a large pool of international specialists. R&D collaborates with universities and start-ups. The strength and prioritization of intellectual property protection is globally renowned.

Swiss exports from medical device companies in the Greater Zurich Area have helped sustain life and treat rare conditions across the globe.